文献速递先天性心脏病外科

肺动脉环缩术的当代应用与结局:基于胸外科医师学会先天性心脏病手术数据库的分析

Contemporary Applications and Outcomes of Pulmonary Artery Banding: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database.
PubMed 文献 · Ann Thorac Surg · 2023-09-28

基于STS先天性心脏病手术数据库2016至2019年数据,共识别3367例肺动脉环缩术(占同期心血管病例3%),其中主肺动脉环缩2677例、双侧环缩690例。主肺动脉环缩手术死亡率为8%,双侧环缩为26%。主肺动脉环缩使用在各中心间存在显著差异,且在主肺动脉环缩患者中,若在住院期间其他独立手术后进行(最常见为体外膜肺氧合后),手术死亡率最高达25%(P < .0001)。

要点

  • 主肺动脉环缩手术死亡率为8%,双侧环缩为26%。
  • 主肺动脉环缩使用在各中心间存在显著差异,115个中心至少实施1例(范围1-134例;Q1-Q3,8-33)。
  • 主肺动脉环缩在住院期间其他独立手术后进行者手术死亡率最高为25%(P < .0001),最常见的前序手术为体外膜肺氧合。

核心结论

  • 肺动脉环缩是常用的先天性心脏病手术,死亡率高且各中心使用存在差异;结局因环缩类型和患者诊断而异;主肺动脉环缩在心脏手术后(尤其体外膜肺氧合后)进行与极高的手术死亡率相关。

研究设计与样本

  • 基于胸外科医师学会先天性心脏病手术数据库(STS CHSD)的回顾性分析,通过手术和诊断代码识别2016年至2019年接受肺动脉环缩术的患者,分为主肺动脉环缩组和双侧环缩组,重点描述主肺动脉环缩患者结局。

主要发现

  • 2016年至2019年共识别3367例肺动脉环缩术,占同期STS CHSD心血管病例的3%;其中主肺动脉环缩2677例,双侧环缩690例。
  • 主肺动脉环缩后手术死亡率为8%,双侧环缩后为26%。
  • 115个中心至少实施1例主肺动脉环缩,使用例数范围为1-134例(Q1-Q3,8-33),各中心间使用存在显著差异。
  • 主肺动脉环缩患者中,手术死亡率因主肺动脉环缩相对于其他手术的时间不同而存在显著差异;住院期间其他独立手术后进行主肺动脉环缩者手术死亡率最高,为25%(P < .0001),体外膜肺氧合是最常见的前序手术。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary artery banding (PAB) in isolation or combined with a congenital cardiac surgical procedure is common and has important mortality. We aimed to determine patient characteristics, clinical outcomes, variation in clinical outcomes by diagnoses, and center variation in PAB use. METHODS: Using The Society of Thoracic Surgeons Congenital Heart Surgery Database (STS CHSD), this study evaluated outcomes of patients undergoing PAB across diagnoses, participating centers, and additional procedures. Patients were identified by procedure and diagnosis codes from 2016 to 2019. We separated patients into groups of main and bilateral PAB and described their outcomes, focusing on patients with main PAB. RESULTS: This study identified 3367 PAB procedures from 2016 to 2019 (3% of all STS CHSD cardiovascular cases during this period): 2677 main PAB, 690 bilateral PAB. Operative mortality was 8% after main PAB and 26% after bilateral PAB. There was significant variation in use of main PAB by center, with 115 centers performing at least 1 main PAB procedure (range, 1-134; Q1-Q3, 8-33). For patients with main PAB, there were substantial differences in mortality, depending on timing of main PAB relative to other procedures. The highest operative mortality (25%; P < .0001) was in patients who underwent main PAB after another separate procedure during their admission, with extracorporeal membrane oxygenation being the most frequent preceding procedure. CONCLUSIONS: PAB is a frequently used congenital cardiac procedure with high mortality and variation in use across centers. Outcomes vary widely by banding type and patient diagnosis. Main PAB after cardiac surgical procedures, especially extracorporeal membrane oxygenation, is associated with very high operative mortality.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Devlin PJ, Argo M, Habib RH, et al. Contemporary Applications and Outcomes of Pulmonary Artery Banding: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database. Ann Thorac Surg. 2023. PMID: 37774761. doi:10.1016/j.athoracsur.2023.09.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。